Congresos

NEUROSCIENCE 2021

Cannabidiol modulates behavioral and gene expression alterations induced by spontaneous heroin withdrawal

2ND INTERNATIONAL CONGRESS Y XLVII JORNADAS NACIONALES DE SOCIDROGALCOHOL

Uso del Cannabidiol para el tratamiento del abuso de alcohol

1ST INTERNATIONAL CONGRESS Y XLVI JORNADAS NACIONALES DE SOCIDROGALCOHOL

Potencial terapéutico del cannabidiol en el manejo del trastorno por uso de alcohol

32ND ECNP CONGRESS

Increased vulnerability to ethanol voluntary consumption in a new long-lasting animal model of post-traumatic stress disorder in C57BL/6J mice

III WORLD CONGRESS AND VI INTERNATIONAL CONGRESS OF DUAL DISORDERS

Effects of cannabidiol plus sertraline on fear conditioning and anxiety-like behavior in a new long-lasting animal model of post-traumatic stress disorder

III WORLD CONGRESS AND VI INTERNATIONAL CONGRESS OF DUAL DISORDERS

A new animal model simulating dual pathology post-traumatic stress disorder and increased ethanol consumption in mice

SOCIETY FOR NEUROSCIENCE 2019

Cannabidiol and sertraline-mediated regulation of behavioral and neurochemical disturbances induced by a new long-lasting animal model of post-traumatic stress disorder

32ND ECNP CONGRESS

Acute and Chronic dose-response effects of cannabidiol on heavy alcohol drinking in male and female mice

XLV JORNADAS NACIONALES DE SOCIDROGALCOHOL

Modelos experimentales en adicciones y biomarcadores cerebrales en dependencia

THE 18TH WPA WORLD CONGRESS OF PSYCHIATRY

Effects of Cannabidiol in a new post-traumatic stress disorder-like model in mice

THE 18TH WPA WORLD CONGRESS OF PSYCHIATRY

Role of 5HT1A receptors in the efficacy of cannabidiol plus naltrexone to reduce ethanol consumption and motivation to drink

Evaluation of the analgesic efficacy of spinal cord stimulation for patients with treatment-resistant failed back surgery syndrome, and associated gene expression changes in peripheral blood lymphocytes

Altered acetylcholinesterase expression in Alzheimer¿s disease. Contribution of the proline-rich membrane anchor processing by gamma-secretase

Discuso foro de debate del cigarrillo electrónico

Methylphenidate, but not antipsychotics, improves prepulse inhibition deficits displayed by CB1 knockout mice

Attentional bias and inhibitory behavioral changes in patients with alcohol dependence and bipolar disorders treated with aripiprazole

Deletion of cannabinoid CB2 receptor induces schizophrenia-like behaviours and increases ethanol reinforcing effects in mice

Cannabinoid CB2 receptor gene expression differences in post-mortem brain and lymphocytes samples from Parkinson’s disease patients

Cannabinoid CB2 Receptor Gene and Protein Expression Differences in Parkinson’s Disease Post-Mortem Brain Samples and Lymphocytes from Recently Diagnosed and Non-Treated Patients

Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB2 receptors

Workshop on Neuropsychopharmacology for Young Scientist in Europe

Chronic blockade of CB2r resulted in anxiolytic action associated with increased GABAA-alpha-2 and GABAA-gamma-2 receptor subunits gene expression in the amygdala of mice

Aversive effects of naloxone induce an enhancement of mu opioid receptor gene expression

Accumbal dopamine, noradrenaline and serotonine activity throughout expression of place conditioning

Decrease vulnerability to intracaudate lesion of 6-hydroxydopamine in mice overexpressing CB2 receptors

Deletion of the prodynorphin gene increased vulnerability to ethanol consumption associated to changes in tyrosine hydroxilase, proenkephalin and dopamine transporter gene expressions and opioid receptors functional activities

Increased anxiety-like behaviors and impaired anxiolytic response to benzodiazepines in prodynorphin knock out mice is associated to alterations in GABA A receptor subunits gene expression and MAPK signaling pathway

Cocaine fails to induce sensitization to motor responses in transgenic mice overexpressing cannabinoid CB2 receptors

Intrathecal administration of subeffective doses of a cannabinoid reuptake inhibitor combined with µ-opioid or CB1 receptor agonists produced a synergistic antinociception action

Dopamine and cannabinoid receptors gene alterations and high impulsivity between two strains of mice

Administration of cannabinoid CB2 receptor antagonist AM630 decreased emotional-like behaviors after acute and chronic depressive stimuli

Attentional bias associated with cocaine cues: differences among cocaine dependents, occasional cocaine users and controls

Overexpression of cannabinoid CB2 receptors decreased the response of emotional behaviors to anxiogenic stimuli and impaired the anxiolytic actions of benzodiazepines

Time course of changes in mu-opioid receptor-stimulated [35S] GTP-gamma-S binding autoradiography during the extinction of morphine self-administration in Fischer 344 and Lewis rats

Mice deficient in cannabinoid CB1 receptors display a high level of anxiety and depression states

Effects of chronic stress on cannabinoid CB1 receptor function in regions of the rat brain

Spontaneous cannabinoid withdrawal produces a differential time related responsiveness in CB1 receptor gene expression in the mouse brain

Comparison between gabapentine and acamprosate in the treatment of alcohol dependence patients

Acute and chronic alcohol treatment differentially affects proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the male rat

Changes in proenkephalin and tyrosine-hydroxilase gene expression induced by spontaneous cannabinoid withdrawal in mice

Gastrin-releasing peptide mediated regulation of 5-HT neuronal activity in the hypothalamic paraventricular nucleus under basal and restraint stress conditions

Prenatal delta-9-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences

Changes in proenkephalin gene expression during the extinction of cocaine-self administration in several rat brain regions

Proenkephalin gene expression changes in the nucleus accumbens and substantia nigra after the extinction of cocaine self-administration in Lewis rats

Preclinical pharmacology of B-20991, a new and selective 5-HT1A agonist receptor with anxiolytic activity

Preliminary in vivo characterization of EF-7412, a pre- and postsynaptic 5HT1A receptor antagonist

Endogenous tonic inhibitory action of dynorphin on the activity of periventricular-hypophysial dopaminergic neurons

Delta opioid receptor-mediated regulation of central dopaminergic neurons

Alcohol inhibition of suckling-induced prolactin release may be mediated by reduction in hypothalamic (HT) serotoninergic activity

Evidence that photoperiod-induced decreases in median eminence dopamine concentrations in male Syrian hamsters is not due to a change in tyrosine hydroxylase activity

Effects of a kappa opioid receptor agonist on different dopaminergic neuronal systems in the male rat brain

Plasmatic somatostatin a state marker of psychopathology in schizophrenia

Cannabidiol modulates behavioral and gene expression alterations induced by spontaneous heroin withdrawal

33RD ECNP

Sertraline plus naltrexone reduced ethanol consumption and motivation in mice exposed to a chronic animal model of post-traumatic stress disorder

CONGRESO LIII NACIONAL Y VIII INTERNACIONAL DE CIENCIAS FARMACEUTICAS

Intervención del Cannabidiol en la regulación de la dependencia por el consumo de alcohol en modelos animales

Miembros del Comité Organizador de un Congreso o del Comité Científico

ESCENARIOS DE FORMACIÓN Y CAPACITACIÓN FARMACÉUTICA EN EL SECTOR PRODUCTIVO Y DE SERVICIOS ANTE LA NUEVA REALIDAD

SIMPOSIO IBEROAMERICANO COIFFA

Experiencias en el diseño de prácticas profesionales, tuteladas y prácticas de laboratorio

CANNABIS AND CANNABINOIDS: CHEMISTRY, PHARMACOLOGY AND CLINICAL APPLICATIONS

Role of cannabidiol in the ethanol intake regulation: dual ethanol-TEPT paradigm in mouse

33RD ECNP

Cannabidiol-mediates effects on behavioural and gene expression changes induced by a new animal model of spontaneous cocaine withdrawal

32ND ECNP CONGRESS

Effects of cannabidiol and sertraline on behavioural and neurochemical alterations induced by a new mong-lasting animal model of PTSD

LXXI REUNION ANUAL SOCIEDAD ESPAÑOLA NEUROLOGIA

¿Podemos predecir la aparición de síntomas psicóticos en los pacientes con enfermedad de Alzheimer en la fase de deterioro cognitivo leve? Estudio preliminar

1ST INTERNATIONAL CONGRESS Y XLVI JORNADAS NACIONALES DE SOCIDROGALCOHOL

15 años dep la Red de Trastornos Adictivos. El valor añadido de la investigación cooperativa en adicciones

32ND ECNP CONGRESS

Alterations in gene expression of Homer1a and mGluR5 in brain areas close related with emotional response in suicide completers

SOCIETY FOR NEUROSCIENCE 2019

Alterations of the postsynaptic plasticity genes Homer1a and mGluR5 in the dorsolateral prefrontal cortex, amygdala and hippocampus of suicide completers

20 JORNADAS NACIONALES DE PATOLOGIA DUAL

Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal

LI CONGRESO NACIONAL DE CIENCIAS FARMACEUTICAS

Debate conversatorio sobre aspectos regulatorios del uso de Cannabis

THE 18TH WPA WORLD CONGRESS OF PSYCHIATRY

What is the significance of animal models in psychiatry? Comunicación Panel o Poster

SOCIETY FOR NEUROSCIENCE

Drugs of abuse and addiction: alcohol: other behavioral effects

SOCIETY FOR NEUROSCIENCE

Effects of a new post-traumatic stress disorder animal model on anxiety-like behaviors and ethanol voluntary consumption in C57BL/6J mice

THE 18TH WPA WORLD CONGRESS OF PSYCHIATRY

The role of receptors CB2 in memory and mental disorders Comunicación Panel o Poster

Cerebrospinal fluid alpha-Synuclein in Mild Cognitive Impairment Patients. A Preliminary Study.

Acetylcholinesterase expression levels in Alzheimer¿s. Role of the processing of the proline-rich membrane anchor by ¿-secretase

Análisis de alfa-sinucleína en L.C.R. de pacientes con deterioro cognitivo leve que evolucionaron a enfermedad de Alzheimer o demencia con cuerpos de Lewy

Papel del cannabidiol en la regulación de la adicción al alcohol.

DLK1 gene deletion increased anxiety-like behaviours and ethanol consumption in mice

Expresión génica de los receptores cannabinoides CB2 en linfocitos de pacientes con enfermedad de Alzheimer y demencia con cuerpos de Lewy

Evaluación de los efectos del cannabidiol en un nuevo modelo crónico de Trastorno de Estrés Post-traumático

The administration of cannabidiol reduced the spontaneous withdrawal syndrome induced by CP-55,940

Genetic and pharmacological manipulation of the cannabinoid receptor 2 modulates ethanol-induced reinforcement and motivation

Increaed vulnerability to ethanol consumpttion in adolescent maternal separated mice

Social defeat in adolescent mice increases vulnerability to alcohol consumption

Increased ethanol self-administration associated with synaptic plasticity alterations induced by early life stress in mice

Influencia de las alteraciones neurobiológicas y conductuales inducidas por separación maternal en el consumo de alcohol durante la adolescencia en ratones

Caracterización neurobiológica y conductual inducida por separación maternal y vulnerabilidad por el consumo de alcohol en ratones

Gender differences in the anxiolytic action of benzodiazepines: roles of CB1 and GABAA receptors

Differential regulation of sensorimotor-gating deficit in CB1 knockout mice by haloperidol, risperidone and methylphenidate

Deletion of cannabinoid CB2 receptor induces schizophrenia-like behaviors and increases ethanol reinforcing effects in mice

Overexpression of cannabinoid CB2 receptors attenuated the progressive motor impairment and nigrostriatal dopaminergic neurons loss in Mitopark mouse

Role of cannabinoid CB2 receptor in the development of psychiatric disorders and drug addiction with special focus on vulnerability to alcohol and nicotine consumption

Effects of systemic administration of desketoprofen in a post-incisional pain model and CB1r and CB2r gene expression changes in periaqueductal grey and lumbar spinal cord

How to design animal models of dual pathology with translational projection. The experience of cannabinoid CB2 receptor and nicotine in mice

Synergistic action of naltrexone plus topiramate on ethanol self-administration and associated neurochemical changes in C57BL/6 mice

Cannabinoid CB2 receptor gene expression alterations in the dorsolateral prefrontal cortex and amygdala of suicide victims

Cannabinoid CB2 receptor gene expression differences in Parkinson's disease post-mortem brain samples and lymphocytes from recently diagnosed and non-treated patients

CB2 cannabinoid receptor is involved in schizophrenia-like behaviors

Cocaine fails to induce sensitization to motor responses in transgenic mice overexpressing cannabinoid CB2 receptors

Cannabinoid receptor activation reduced abnormal involuntary movements and tyrosine hydroxylase loss in caudate-putamen of mice lesioned with 6-ohda and treated with L-DOPA

Antinociceptive action of intrathecal morphine plus cannabinoid reuptake inhibitor in incisional pain

Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice

Effects of pregabalin and topiramate on impulsive control and certain impulsive-related behaviors

Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice

Pregabalin and topiramate regulate behavioral and brain gene transcription changes induced by cannabinoid withdrawal in mice

Overexpression of CB2r results in decreased response to acute anxiogenic-like stimuli and impaired anxiolytic action of alprazolam

Pregabalin and topiramate actions on behavioral and gene transcription alterations associated with cannabinoid spontaneous withdrawal

Resistant depressive-like behaviors in transgenic mice overexpressing cannabinoid CB2 receptors

Cannabinoid CB2 receptor mediated regulation of impulsive-like behaviors in mice

Blockade of cannabinoid CB2 receptors modulates impulsive-like behaviors in DBA/2J mice

Dopamine DrD2 and cannabinoid CB1 and CB2 receptors gene differences and distinct patterns of impulsive-like behaviors in mice

Lactacystin requires reactive oxygen species and bax redistribution to induce mitochondria-mediated cell death

Overexpression of cannabinoid CB2 receptors results in decreased behavioral and neurochemical vulnerability to intracaudate administration of 6-hydroxydopamine

Overexpression of cannabinoid CB2 receptors results in decreased response to acute and chronic depressive stimuli

Molecular basic of how Lactacystin activates the mitochondrial-mediated apoptotical pathway

Motor and non-motor behavioral impairments associated to decreased expression of tyrosine hydroxylase after intracerebral administration of lactacystin

Depressive-resistant behavioral phenotype in mice overexpressing cannabinoid CB2 receptors

Role of endocannabinoid signaling in voluntary alcohol consumption: differences in CB1 receptor function in sP and sNP rats

Administration of the cannabinoid receptor agonist CP-55,940 reduced motor impairment and tyrosine hydroxylase expression loss in 6-hydroxydopamine-lesioned mice

Deletion of the prodynorphin gene increases anxiety-like behaviors and modify POMC, CRF and CB1 receptor gene expressions in response to restraint stress

Long term effects of intracaudate administration of lactacystin on motor, emotional and cognitive behaviors and the expression of tyrosine hydroxylase in the basal ganglia

Crucial role of the CB2 cannabinoid receptor in the regulation of central immune responses during neuropathic pain

Mice deficient in prodynorphin exhibit increased vulnerability to anxiety-like behaviors and reduced response to the anxiolytic action of bromazepam

Overexpression of the cannabinoid CB2 receptor results in an anxiety-resistant behavioral phenotype non-responding to the anxiolytic actions of alprazolam

Antinociception action of spinal subeffective doses of cannabinoid agonist CB1 combined with an inhibitor of the fatty acids amide hydrolase (FAAH) in rats

Increased vulnerability to ethanol preference consumption in prodynorphin knock out mice is associated to decrease opioid function in selected areas of the brain

Dose response comparison of spinal agonist opioid morphine and spinal agonist cannabinoid CP- 55,940 for antinociception in a hot-plate model in rats

Enhanced conditioned place preference and voluntary ethanol consumption in mice lacking the prodynorphin gene is associated to reduced opioid functional activity in the brain

Cannabinoid CB1 receptor mediated regulation of anxiolytic, sedative and amnesic actions of benzodiazepines

Increased neurological impairment in cannabinoid CB1 receptor knock out mice after 6-OHDA lesion in the caudate-putamen nucleus

Subeffective doses of intrathecal morphine and anandamide uptake inhibitor produces a synergistic antinociceptive action without affecting µ-opioid or cannabinoid receptors

The administration of the cannabinoid CB1 receptor antagonist AM-251 blocked the anxiolytic and sedative actions of benzodiazepines

Alterations in the functional activity of the prodynorphin gene expression in selected brain regions are associated to increased preference for ethanol and the development of dependence

Role of cannabinoid CB1 receptors in the development and control of dyskinesias in mice lesioned with 6-hydroxydopamine

Adjunctive topiramate in treatment of resistant obsessive-compulsive disorder

Time course effects of donepezil, ziprasidone or simultaneous administration of both drugs on motor activity, anxiolytic response, and short and long term memories in mice

Repeated administration of topiramate induces pronounced anxiolytic effects without alterations in body weight and fluid or food consumption in rats

Increased anxiety-like behaviors in male deficient in prodynorphin gene

Naltrexone decreases ethanol intake and alter opioid and tyrosine hydroxylase gene expression in Fawn-Hooded rats

Acute and chronic stress alter the endogenous cannabinoid system in the rat brain

Effects of the cannabinoid receptor antagonist AM-251 in ethanol preferring Fawn Hooded rats

Role of CB1 cannabinoid receptor in the regulation of anxiety behaviors and the efficacy of anxiolytic drugs

Role of gonadal steroids in the anxiolytic action of benzodiazepines in male and female mice lacking cannabinoid CB1 receptors

Effects of AM-251on voluntary ethanol intake and opioid functional activity in brain and pituitary regions of Fawn-Hooded rats

Role of the endogenous cannabinoid CB1 receptor in the regulation of anxiety

El impacto de la co-morbilidad depresiva (y del deterioro agudo de funciones cognoscitivas) en pacientes geriátricos y no geriátricos hospitalizados en plantas médicas y seguidos en Atención Primaria

Effects of bromazepam and buspirone on anxiety-related behaviors in mice lacking cannabinoid CB1 receptors

Role of the endogenous cannabinoid system in nociception and cannabinoid withdrawal

Effects of naltrexone on proenkephalin gene expression-induced alterations by chronic alcohol consumption in brain areas of the rat

Differences in basal cannabinoid and opioid functional activity in selective brain areas and vulnerability to alcohol consumption between Wistar and Fawn Hooded rats

ADHD as predictor of response to naltrexone in the treatment of alcohol dependence in men

Chronic and intermittent alcohol consumption differentially alter cannabinoid receptor function in the caudate-putamen of non-alcohol preferring rats

Behavioral and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice

Altered emotional states and impaired anxiolytic action of benzodiazepines in mice lacking cannabinoid CB1 receptors

Chronic treatment with fluoxetine produced time related alterations in opioid, cannabinoid and tyrosine hydroxylase gene expression in selected regions of the rat brain

Predictors of response to naltrexone in the treatment of alcohol dependence in men

MAO-platelet activity as outcome variable in alcohol dependence treatment with naltrexone

Changes in opioid gene transcripts in alcohol preferring and non-preferring male rats

Acute alcohol administration induces a time dependent increase in proenkephalin gene expression in brain rats

Cannabinoid interactions with the endogenous opioid system in relation to addiction and nociception

Semiautomatic method for volumetric measurement and segmentation in brain imaging to study neurological diseases

Time related behavioral alterations after spontaneous cannabinoid withdrawal in mice

Repeated administration of d9-tetrahydrocannabinol produces a differential time-related regulation of µ-opioid receptors in the rat brain

Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland

AM404, an inhibitor of the endocannabinoid uptake, attenuated motor hyperactivity in a rat model of Huntington’s disease

Prenatal delta-9-tetrahydrocannabinol exposure modifies opioid peptide gene expression in the fetal rat brain: sex-dependent differences

Intrastriatal NMDA exposure induces a rapid and wide-spread loss of cannabinoid receptor binding and mRNA expression in the neonatal rat brain

Changes in CB1 receptors in the basal ganglia of rats subjected to intrastriatal injections of 3-nitropropionic acid, an animal model of Huntington´s disease

Corticosterone response to acute and chronic intravenous heroin administration in Lewis rats

Role of estradiol and dihydrotestosterone in the effects of delta-9-THC on corticotropin releasing factor and proenkephalin gene expression in the hypothalamic paraventricular nucleus (PVN) of male and female rats

Time dependent differences of repeated administration with delta-9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by µ-opioid and cannabinoid receptors in the caudate-putamen

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased cannabinoid CB1 receptor mRNA levels in the rat striatum: possible therapeutic implications

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased cannabinoid CB1 receptor mRNA levels in striatal efferent neurons

Gonadal steroids role in the effects of delta-9-THC on PENK and POMC gene expression in the hypothalamus of male and female rats

Corticotropin releasing factor and gastrin-releasing peptide are differentially involved in the activation of 5-HT neurons induced by restraint stress in the hypothalamic paraventricular nucleus in male rats

Role of estradiol and testosterone in the effects of delta-9-tetrahydrocannabinol on proenkephalin and proopiomelanocortin in the mediobasal hypothalamus of male and female rats

Withdrawal from long-term cocaine self-administration alters proopiomelanocortin, proenkephalin and corticotropin releasing factor mRNA content in several rat brain regions

Electrophysiological effects of the 5-HT1A receptor agonist B-20991 on dorsal raphe serotonin neurons in adult rat

Time-course of the CB1 receptor down-regulation in the adult brain caused by chronic exposure to delta-9-THC

Acute and repeated electroconvulsive shock increases corticotropin-releasing factor, proopiomelanocortin and proenkephalin gene expression in selected regions of the rat hypothalamus

Gastrin-releasing peptide (GRP)-mediated regulation of ACTH and corticosterone secretion in male rats involves the activation of CRF gene expression in the paraventricular nucleus of the hypothalamus

Withdrawal from long-term cocaine self-administration in Lewis rats increases corticotropin releasing factor gene expression in the paraventricular nucleus of the hypothalamus

Differences in opioid basal activity in the striatum and nucleus accumbens of Fischer344 and Lewis inbred rat strains

Cannabinoid receptor agonist CP-55,940 increases corticotropin releasing factor, proopiomelanocortin and proenkephalin gene expression in the rat brain

RU-486 blocked the stimulatory increase of stress in the expression of proenkephalin in the paraventricular nucleus of the hypothalamus

Gastrin-releasing peptide regulation of corticosterone secretion in rats

Subchronic administration of -9-Tetrahydrocannabinol (THC) increases proopioimelanocortin gene expression in the arcuate nucleus of the hypothalamus

Estradiol and dihydrotestosterone-mediated regulation of proenkephalin gene expression in the rat brain

B-20991, a novel selective 5HT1A receptor agonist with a potential anxiolytic profile

Preliminary pharmacological characterization of B-20991, a selective 5HT1A receptor agonist

Effects of delta-9-THC perinatal treatment of mothers on morphine and food operant reinforced behaviors in the adult offspring

Aminoacid levels following ventricular injection of ß-amyloid to rats

Role of gonadal steroids in the responsiveness of kappa opioid receptor agonist and antagonist in the activity of tuberoinfundibular dopaminergic neurons

Effects of gender and photoperiod on tuberoinfundibular dopamine neurons in Syrian hamsters

Effects of immunoneutralization of dynorphin1-17 and dynorphin1-8 on the activity of central dopaminergic neurons in the male rat

Differential effects of kappa and delta opioid agonists on dopaminergic neurons in the male rat brain

Acción tónica inhibitoria de los opioides kapa sobre la actividad dopaminérgica en la eminencia media y el lóbulo intermedio de la hipófisis de la rata macho

Kappa opioid regulation of the secretion of prolactin and alpha-melanocyte-stimulating-hormone in male and female rats

Comparison of the effects of photoperiod on the activity of tuberoinfundibular DA neurons in intact and gonadectomized male Syrian hamsters

Sexual differences in the responsiveness of tuberoinfundibular dopaminergic neurons to central administration of bombesin

Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons

Evidence that 5-HT2 receptors mediate the inhibitory effects of stress on the activity of tuberoinfundibular and tuberohypophysial dopaminergic neurons in female rats

Norbinaltorphimine activates tuberoinfundibular and tuberohypophysial but not nigrostriatal or mesolimbic dopamine neurons in the male rat

Evidence for a role of kappa opioids in the tonic regulation of tuberohypophysial dopamine (THDA) neurons in the male rat

Depletion of norepinephrine in the ventromedial nucleus fails to inhibit lordosis in female rats

Depletion of norepinephrine in either the ventromedial nucleus or the medial preoptic nucleus fails to alter lordosis in rats

Kappa opioid receptor-mediated regulation of tuberohypophysial dopamine (THDA) neurons and the secretion of -melanocyte stimulating hormone (alpha-MSH) in the male rat

Bombesin activates tuberoinfundibular (TI) and tuberohypophysial (TH) dopamine (DA) neurons and decreases basal and stress-induced secretion of prolactin and alpha-melanocyte stimulating hormone (MSH) in the male rat

Role of hypothalamic dopaminergic neurons in mediating the inhibitory effects of bombesin on prolactin and alpha-melanocyte stimulating hormone secretion during stress

The role of kappa opioid receptor-mediated mechanisms in the regulation of tuberohypophysial dopaminergic neurons and the secretion of alpha-melanocyte stimulating hormone

Alterations in concentrations of 3-metoxy-4-hydroxyphenylethyleneglicol (MHPG) in the paraventricular nucleus and supraoptic nucleus reflect the activity of noradrenergic neurons projecting to these hypothalamic regions

Ceruletide and haloperidol decreased insulin levels and increased DOPAC/DA in limbic forebrain

NEUROSCIENCE 2021

Cannabidiol modulates behavioral and gene expression alterations induced by spontaneous heroin withdrawal